Aspen Pharmacare Holdings Ltd APN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if APN is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- ZAC 22,667.00
- Day Range
- ZAC 22,488.00–22,939.00
- 52-Week Range
- ZAC 16,096.00–22,939.00
- Bid/Ask
- ZAC 22,314.00 / ZAC 22,955.00
- Market Cap
- ZAC 10.12 Tril
- Volume/Avg
- 641,018 / 1.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 14.58
- Price/Sales
- 2.37
- Dividend Yield (Trailing)
- 1.50%
- Dividend Yield (Forward)
- 1.50%
- Total Yield
- 1.56%
Company Profile
Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) – this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin – this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 9,161
- Website
- https://www.aspenpharma.com
Comparables
Valuation
|
Metric
|
APN
|
524742
|
300702
|
|---|---|---|---|
Price/Earnings (Normalized) | 14.58 | 22.56 | 208.12 |
Price/Book Value | 1.18 | 4.76 | 1.90 |
Price/Sales | 2.37 | 6.09 | 2.69 |
Price/Cash Flow | 13.40 | 25.68 | 55.46 |
Price/Earnings
APN
524742
300702
Financial Strength
|
Metric
|
APN
|
524742
|
300702
|
|---|---|---|---|
Quick Ratio | 1.09 | 4.03 | 0.37 |
Current Ratio | 1.92 | 5.67 | 1.16 |
Interest Coverage | 3.77 | 631.76 | −0.80 |
Quick Ratio
APN
524742
300702
Profitability
|
Metric
|
APN
|
524742
|
300702
|
|---|---|---|---|
Return on Assets (Normalized) | 5.10% | — | 0.38% |
Return on Equity (Normalized) | 8.14% | — | 0.68% |
Return on Invested Capital (Normalized) | 6.61% | — | 1.26% |
Return on Assets
APN
524742
300702
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Pdxylgqt | Ysrs | $76.2 Bil | |
MKKGY
| Merck KGaA ADR | Bhtvtvtcs | Spsvxs | $70.9 Bil | |
HLN
| Haleon PLC ADR | Cfzrwdch | Nyn | $37.8 Bil | |
VTRS
| Viatris Inc | Wqkkpwxs | Ykvn | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Pkgfftb | Plng | $12.7 Bil | |
CTLT
| Catalent Inc | Dtgmypfls | Bfjhdpj | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Pcldgzcn | Vcx | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Rtrspgfy | Nqbt | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Jkywdyl | Vdwgcj | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Mgtccppvd | Ftpt | $3.1 Bil |